vs
Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and SEALED AIR CORP (SEE). Click either name above to swap in a different company.
SEALED AIR CORP is the larger business by last-quarter revenue ($1.4B vs $950.5M, roughly 1.5× Astrana Health, Inc.). SEALED AIR CORP runs the higher net margin — 3.1% vs 0.7%, a 2.5% gap on every dollar of revenue. On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs 2.6%). SEALED AIR CORP produced more free cash flow last quarter ($257.7M vs $-6.0M). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs 2.7%).
Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.
Sealed Air Corporation is a global provider of innovative packaging and protective solutions. Its core offerings include cushioning materials, food safety and preservation packaging, and sustainable waste-reducing packaging systems, serving retail, e-commerce, food and beverage, and industrial manufacturing markets worldwide.
ASTH vs SEE — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $950.5M | $1.4B |
| Net Profit | $6.6M | $43.8M |
| Gross Margin | — | 28.6% |
| Operating Margin | 1.9% | 11.4% |
| Net Margin | 0.7% | 3.1% |
| Revenue YoY | 42.9% | 2.6% |
| Net Profit YoY | 184.4% | 700.0% |
| EPS (diluted) | $0.12 | $0.30 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $950.5M | $1.4B | ||
| Q3 25 | $956.0M | $1.3B | ||
| Q2 25 | $654.8M | $1.3B | ||
| Q1 25 | $620.4M | $1.3B | ||
| Q4 24 | $665.2M | $1.4B | ||
| Q3 24 | $478.7M | $1.3B | ||
| Q2 24 | $486.3M | $1.3B | ||
| Q1 24 | $404.4M | $1.3B |
| Q4 25 | $6.6M | $43.8M | ||
| Q3 25 | $373.0K | $255.1M | ||
| Q2 25 | $9.4M | $93.1M | ||
| Q1 25 | $6.7M | $113.5M | ||
| Q4 24 | $-7.8M | $-7.3M | ||
| Q3 24 | $16.1M | $91.7M | ||
| Q2 24 | $19.2M | $98.3M | ||
| Q1 24 | $14.8M | $82.0M |
| Q4 25 | — | 28.6% | ||
| Q3 25 | — | 29.8% | ||
| Q2 25 | — | 30.7% | ||
| Q1 25 | — | 30.9% | ||
| Q4 24 | — | 30.0% | ||
| Q3 24 | — | 30.1% | ||
| Q2 24 | — | 31.2% | ||
| Q1 24 | — | 30.3% |
| Q4 25 | 1.9% | 11.4% | ||
| Q3 25 | 2.0% | 13.8% | ||
| Q2 25 | 3.1% | 15.0% | ||
| Q1 25 | 3.3% | 14.5% | ||
| Q4 24 | 0.1% | 11.7% | ||
| Q3 24 | 5.9% | 13.9% | ||
| Q2 24 | 6.2% | 15.4% | ||
| Q1 24 | 7.5% | 14.0% |
| Q4 25 | 0.7% | 3.1% | ||
| Q3 25 | 0.0% | 19.0% | ||
| Q2 25 | 1.4% | 7.0% | ||
| Q1 25 | 1.1% | 9.0% | ||
| Q4 24 | -1.2% | -0.5% | ||
| Q3 24 | 3.4% | 6.9% | ||
| Q2 24 | 3.9% | 7.4% | ||
| Q1 24 | 3.7% | 6.2% |
| Q4 25 | $0.12 | $0.30 | ||
| Q3 25 | $0.01 | $1.73 | ||
| Q2 25 | $0.19 | $0.63 | ||
| Q1 25 | $0.14 | $0.77 | ||
| Q4 24 | $-0.14 | $-0.05 | ||
| Q3 24 | $0.33 | $0.63 | ||
| Q2 24 | $0.40 | $0.67 | ||
| Q1 24 | $0.31 | $0.56 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $429.5M | $344.0M |
| Total DebtLower is stronger | — | $3.3B |
| Stockholders' EquityBook value | $779.3M | $1.2B |
| Total Assets | $2.2B | $7.0B |
| Debt / EquityLower = less leverage | — | 2.65× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $429.5M | $344.0M | ||
| Q3 25 | $463.4M | $282.5M | ||
| Q2 25 | $342.1M | $354.4M | ||
| Q1 25 | $260.9M | $335.2M | ||
| Q4 24 | $290.8M | $371.8M | ||
| Q3 24 | $350.3M | $386.0M | ||
| Q2 24 | $327.7M | $388.6M | ||
| Q1 24 | $337.3M | $352.8M |
| Q4 25 | — | $3.3B | ||
| Q3 25 | — | $4.0B | ||
| Q2 25 | — | $4.0B | ||
| Q1 25 | — | $4.2B | ||
| Q4 24 | — | $4.2B | ||
| Q3 24 | — | $4.3B | ||
| Q2 24 | — | $4.4B | ||
| Q1 24 | — | $4.5B |
| Q4 25 | $779.3M | $1.2B | ||
| Q3 25 | $775.5M | $1.2B | ||
| Q2 25 | $765.5M | $953.1M | ||
| Q1 25 | $745.4M | $797.9M | ||
| Q4 24 | $712.7M | $624.5M | ||
| Q3 24 | $704.6M | $771.2M | ||
| Q2 24 | $678.9M | $650.1M | ||
| Q1 24 | $653.5M | $598.3M |
| Q4 25 | $2.2B | $7.0B | ||
| Q3 25 | $2.2B | $7.1B | ||
| Q2 25 | $1.4B | $7.2B | ||
| Q1 25 | $1.3B | $7.0B | ||
| Q4 24 | $1.4B | $7.0B | ||
| Q3 24 | $1.3B | $7.3B | ||
| Q2 24 | $1.3B | $7.3B | ||
| Q1 24 | $1.2B | $7.2B |
| Q4 25 | — | 2.65× | ||
| Q3 25 | — | 3.34× | ||
| Q2 25 | — | 4.18× | ||
| Q1 25 | — | 5.26× | ||
| Q4 24 | — | 6.72× | ||
| Q3 24 | — | 5.62× | ||
| Q2 24 | — | 6.81× | ||
| Q1 24 | — | 7.49× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.9M | $293.6M |
| Free Cash FlowOCF − Capex | $-6.0M | $257.7M |
| FCF MarginFCF / Revenue | -0.6% | 18.5% |
| Capex IntensityCapex / Revenue | 0.3% | 2.6% |
| Cash ConversionOCF / Net Profit | -0.44× | 6.70× |
| TTM Free Cash FlowTrailing 4 quarters | $104.5M | $458.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.9M | $293.6M | ||
| Q3 25 | $10.0M | $165.9M | ||
| Q2 25 | $90.9M | $136.6M | ||
| Q1 25 | $16.6M | $31.9M | ||
| Q4 24 | $-10.9M | $244.2M | ||
| Q3 24 | $34.0M | $170.5M | ||
| Q2 24 | $23.2M | $188.2M | ||
| Q1 24 | $6.0M | $125.1M |
| Q4 25 | $-6.0M | $257.7M | ||
| Q3 25 | $7.4M | $119.6M | ||
| Q2 25 | $89.5M | $93.2M | ||
| Q1 25 | $13.6M | $-12.0M | ||
| Q4 24 | $-13.5M | $185.1M | ||
| Q3 24 | $31.7M | $115.2M | ||
| Q2 24 | $20.4M | $129.5M | ||
| Q1 24 | $5.6M | $78.0M |
| Q4 25 | -0.6% | 18.5% | ||
| Q3 25 | 0.8% | 8.9% | ||
| Q2 25 | 13.7% | 7.0% | ||
| Q1 25 | 2.2% | -0.9% | ||
| Q4 24 | -2.0% | 13.6% | ||
| Q3 24 | 6.6% | 8.6% | ||
| Q2 24 | 4.2% | 9.7% | ||
| Q1 24 | 1.4% | 5.9% |
| Q4 25 | 0.3% | 2.6% | ||
| Q3 25 | 0.3% | 3.4% | ||
| Q2 25 | 0.2% | 3.3% | ||
| Q1 25 | 0.5% | 3.5% | ||
| Q4 24 | 0.4% | 4.4% | ||
| Q3 24 | 0.5% | 4.1% | ||
| Q2 24 | 0.6% | 4.4% | ||
| Q1 24 | 0.1% | 3.6% |
| Q4 25 | -0.44× | 6.70× | ||
| Q3 25 | 26.69× | 0.65× | ||
| Q2 25 | 9.65× | 1.47× | ||
| Q1 25 | 2.48× | 0.28× | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.11× | 1.86× | ||
| Q2 24 | 1.21× | 1.91× | ||
| Q1 24 | 0.40× | 1.53× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
SEE
| Protective Segment | $1.1B | 78% |
| Other | $292.0M | 21% |
| Pension Plans Defined Benefit | $7.9M | 1% |
